Combined therapy of mitomycin C and Chinese medical herbs on experimental liver cancer.

D. M. Hau; T. H. Chen; J. F. Cheng; J. S. You

doi:10.1142/S0192415X93000078

Combined therapy of mitomycin C and Chinese medical herbs on experimental liver cancer.

D. M. Hau^*, T. H. Chen, J. F. Cheng, J. S. You

^*Corresponding author for this work

National Tsing Hua University

Research output: Contribution to journal › Journal Article › peer-review

4 Scopus citations

Abstract

In this research, ICR male mice were chosen for intrahepatic implantation of sarcoma 180 tumor cells (1 x 10(7)). The mice were randomly divided into various groups 24 hours after implantation. One of the groups was the tumor control, the others were singly or combinedly treated with mitomycin C (MMC) and Shih Chuan-Ta-Pu-Tang (SCTPT) or Shi-Hung-One (SHO). The results revealed that the mortality rate (MR60) in the tumor control was 100% and the mean survival time (MST60) was 21.11 +/- 10.69 days. The best therapeutic effect appeared in the group treated with the combination of MMC and SHO, its MR6o was 55.0% and MST 60 was 47.0 +/- 13.4 days.

Original language	English
Pages (from-to)	51-58
Number of pages	8
Journal	American Journal of Chinese Medicine
Volume	21
Issue number	1
DOIs	https://doi.org/10.1142/S0192415X93000078
State	Published - 1993
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1142/S0192415X93000078

Cite this

@article{42f8d451fbf24b86911ad4aa828f7801,

title = "Combined therapy of mitomycin C and Chinese medical herbs on experimental liver cancer.",

abstract = "In this research, ICR male mice were chosen for intrahepatic implantation of sarcoma 180 tumor cells (1 x 10(7)). The mice were randomly divided into various groups 24 hours after implantation. One of the groups was the tumor control, the others were singly or combinedly treated with mitomycin C (MMC) and Shih Chuan-Ta-Pu-Tang (SCTPT) or Shi-Hung-One (SHO). The results revealed that the mortality rate (MR60) in the tumor control was 100% and the mean survival time (MST60) was 21.11 +/- 10.69 days. The best therapeutic effect appeared in the group treated with the combination of MMC and SHO, its MR6o was 55.0% and MST 60 was 47.0 +/- 13.4 days.",

author = "Hau, {D. M.} and Chen, {T. H.} and Cheng, {J. F.} and You, {J. S.}",

year = "1993",

doi = "10.1142/S0192415X93000078",

language = "英语",

volume = "21",

pages = "51--58",

journal = "American Journal of Chinese Medicine",

issn = "0192-415X",

publisher = "World Scientific",

number = "1",

}

TY - JOUR

T1 - Combined therapy of mitomycin C and Chinese medical herbs on experimental liver cancer.

AU - Hau, D. M.

AU - Chen, T. H.

AU - Cheng, J. F.

AU - You, J. S.

PY - 1993

Y1 - 1993

N2 - In this research, ICR male mice were chosen for intrahepatic implantation of sarcoma 180 tumor cells (1 x 10(7)). The mice were randomly divided into various groups 24 hours after implantation. One of the groups was the tumor control, the others were singly or combinedly treated with mitomycin C (MMC) and Shih Chuan-Ta-Pu-Tang (SCTPT) or Shi-Hung-One (SHO). The results revealed that the mortality rate (MR60) in the tumor control was 100% and the mean survival time (MST60) was 21.11 +/- 10.69 days. The best therapeutic effect appeared in the group treated with the combination of MMC and SHO, its MR6o was 55.0% and MST 60 was 47.0 +/- 13.4 days.

AB - In this research, ICR male mice were chosen for intrahepatic implantation of sarcoma 180 tumor cells (1 x 10(7)). The mice were randomly divided into various groups 24 hours after implantation. One of the groups was the tumor control, the others were singly or combinedly treated with mitomycin C (MMC) and Shih Chuan-Ta-Pu-Tang (SCTPT) or Shi-Hung-One (SHO). The results revealed that the mortality rate (MR60) in the tumor control was 100% and the mean survival time (MST60) was 21.11 +/- 10.69 days. The best therapeutic effect appeared in the group treated with the combination of MMC and SHO, its MR6o was 55.0% and MST 60 was 47.0 +/- 13.4 days.

UR - http://www.scopus.com/inward/record.url?scp=0027355714&partnerID=8YFLogxK

U2 - 10.1142/S0192415X93000078

DO - 10.1142/S0192415X93000078

M3 - 文章

C2 - 8328422

AN - SCOPUS:0027355714

SN - 0192-415X

VL - 21

SP - 51

EP - 58

JO - American Journal of Chinese Medicine

JF - American Journal of Chinese Medicine

IS - 1

ER -

Combined therapy of mitomycin C and Chinese medical herbs on experimental liver cancer.

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this